1. A new method measuring the interaction of radiotracers with the human P-glycoprotein (P-gp) transporter
    Chrysoula Vraka, Monika Dumanic, Teresa Racz, Florian Pichler, Cecile Philippe, Theresa Balber, Eva-Maria Klebermass, Karl-Heinz Wagner, Marcus Hacker, Wolfgang Wadsak, Markus Mitterhauser
    Nuclear Medicine and Biology, 2018,
  2. [18F]FEPPA: Improved Automated Radiosynthesis, Binding Affinity, and Preliminary in Vitro Evaluation in Colorectal Cancer
    Neydher Berroterán-Infante, Theresa Balber, Petra Fürlinger, Michael Bergmann, Rupert Lanzenberger, Marcus Hacker, Markus Mitterhauser, and Wolfgang Wadsak
    ACS Med. Chem. Lett., 2018,
  3. Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice
    Ursula J. Lemberger, Claudia D. Fuchs, Christian Schöfer, Andrea Bileck, Christopher Gerner, Tatjana Stojakovic, Makoto M. Taketo, Michael Trauner, Gerda Egger and Christoph H. Österreicher
    Oncotarget, 2018,
  4. An Overview of PET Radiochemistry, Part 2: Radiometals
    Marie Brandt, Jens Cardinale, Margaret L. Aulsebrook, Gilles Gasser, and
    Journal of Nuclear Medicine, 2018,
  5. An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N
    Verena Pichler, Neydher Berroter ́an-Infante, Cecile Philippe, Chrysoula Vraka, Eva-Maria Klebermass, Theresa Balber, Sarah Pfaff, Lukas Nics, Markus Mitterhauser, and Wolfgang Wadsak
    Journal of Nuclear Medicine, 2018,
  6. Economic analysis of biomarker-based anti-EGFR therapies in metastatic colorectal cancer in the Austrian context
    Dora Niedersüß-Beke, Judit Simon, Michael Schiffinger, Robert M. Made
    Magazine of european medical oncology, 2018,
  1. Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers
    Georg S. Kranz, Andreas Hahn, Christoph Kraus, Marie Spies, Verena Pichler, Johannes Jungwirth, Markus Mitterhauser, Wolfgang Wadsak, Christian Windischberger, Siegfried Kasper, Rupert Lanzenberger,
    NeuroImage, 2018,
  2. EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Thorsten D. Poeppel, Daria Handkiewicz-Junak, Michael Andreeff, Alexander Becherer, Andreas Bockisch, Eva Fricke, Lilli Geworski, Alexander Heinzel, Bernd J. Krause, Thomas Krause, Markus Mitterhauser, Wilfried Sonnenschein, Lisa Bodei, Roberto C. Delgado-Bolton, Michael Gabriel
    European Journal of Nuclear Medicine and Molecular Imaging, 2018,
  3. Speed matters to raise molar radioactivity: Fast HPLC shortens the quality control of C-11 PET-tracers
    Lukas Nics, Britta Steiner, Eva-Maria Klebermass, Cecile Philippe, Markus Mitterhauser , Marcus Hacker, Wolfgang Wadsak
    Nuclear Medicine and Biology, 2017,
  4. Impact of hybrid PET/MR technology on multiparametric imaging and treatment response assessment of cervix cancer
    Michaela Daniel, Piotr Andrzejewski, Alina Sturdza, Katarina Majercakova, Pascal Baltzer, Katja Pinker, Wolfgang Wadsak, Markus Mitterhauser, Richard Pötter, Petra Georg, Thomas Helbich, Dietmar Georg
    Radiotherapy and Oncology, 2017,
  5. Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials
    Judit Fazekas-Singer, Neydher Berroterán-Infante, Christina Rami-Mark, Monika Dumanic, Miroslawa Matz, Michael Willmann, Fritz Andreae, Josef Singer,Wolfgang Wadsak, Markus Mitterhauser, and Erika Jensen-Jarolim
    Oncotarget, 2017,
  6. Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity
    Andreas Hahn, Gregor Gryglewski, Lukas Nics, Lucas Rischka, Sebastian Ganger, Helen Sigurdardottir, Chrysoula Vraka, Leo Silberbauer, Thomas Vanicek, Alexander Kautzky, Wolfgang Wadsak, Markus Mitterhauser, Markus Hartenbach, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger
    Brain Structure and Function, 2017,
  7. Reconsider logP!
    Chrysoula Vraka, Markus Mitterhauser
    Nuclear Medicine and Biology, 2017,
  8. Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
    Marie Spies, Gregory M James, Neydher Berroterán-Infante, Harald Ibeschitz, Georg S Kranz, Jakob Unterholzner, Mathis Godbersen, Gregor Gryglewski, Marius Hienert, Johannes Jungwirth, Verena Pichler, Birgit Reiter, Leo Silberbauer, Dietmar Winkler, Markus Mitterhauser, Thomas Stimpfl, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger,
    International Journal of Neuropsychopharmacology, 2018,
  9. Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas
    Nina Poetsch, Adelheid Woehrer, Johanna Gesperger, Julia Furtner, Alexander R Haug, Dorothee Wilhelm, Georg Widhalm, Georgios Karanikas, Michael Weber, Ivo Rausch, Markus Mitterhauser, Wolfgang Wadsak, Marcus Hacker, Matthias Preusser, Tatjana Traub-Weidinger
    Neuro-Oncology, 2017,
  10. [68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques
    Xiang Li, Daniel Heber, Tatjana Leike, Dietrich Beitzke, Xia Lu, Xiaoli Zhang, Yongxiang Wei, Markus Mitterhauser, Wolfgang Wadsak, Saskia Kropf, Hans J. Wester, Christian Loewe, Marcus Hacker, Alexander R. Haug
    European Journal of Nuclear Medicine and Molecular Imaging, 2017,
  11. In vivo evaluation of radiotracers targeting the melanin-concentrating hormone receptor 1: [11C]SNAP-7941 and [18F]FE@SNAP reveal specific uptake in the ventricular system
    Markus Zeilinger, Monika Dumanic, Florian Pichler, Lubos Budinsky, Wolfgang Wadsak, Katharina Pallitsch, Helmut Spreitzer, Rupert Lanzenberger, Marcus Hacker, Markus Mitterhauser & Cécile Philippe
    Scientific Reports, 2017,
  12. The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning
    A Kautzky, G M James, C Philippe, P Baldinger-Melich, C Kraus, G S Kranz, T Vanicek, G Gryglewski, W Wadsak, M Mitterhauser, D Rujescu, S Kasper & R Lanzenberger
    Translational Psychiatry, 2017,
  13. Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET
    Petra Georg, Piotr Andrzejewski, Pascal Baltzer, Michaela Daniel, Wolfgang Wadsak, Markus Mitterhauser, Alina Sturdza, Katarina Majercakova, Georgios Karanikas, Richard Pötter, Marcus Hacker, Thomas Helbich, Dietmar Georg, Katja Pinker
    Molecular Imaging and Biology, 2017,
  14. LogP, a yesterday's value?
    Chrysoula Vraka, Lukas Nics, Karl-Heinz Wagner, Marcus Hacker, Wolfgang Wadsak, Markus Mitterhauser
    Nuclear Medicine and Biology, 2017,
  15. Expanding LogP: Present possibilities
    Chrysoula Vraka, Sanja Mijailovic, Vanessa Fröhlich, Markus Zeilinger, Eva-Maria Klebermass, Wolfgang Wadsak, Karl-Heinz Wagner, Marcus Hacker, Markus Mitterhauser
    Nuclear Medicine and Biology, 2017,
  16. New approaches for the reliable in vitro assessment of binding affinity based on high-resolution real-time data acquisition of radioligand-receptor binding kinetics
    Markus Zeilinger, Florian Pichler, Lukas Nics, Wolfgang Wadsak, Helmut Spreitzer, Marcus Hacker and Markus Mitterhauser
    EJNMMI Research, 2017,
  17. Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion
    G. Gryglewski, L. Rischka, C. Philippe, A. Hahn, G.M. James, E. Klebermass, M. Hienert, L. Silberbauer, T. Vanicek, A. Kautzky, N. Berroterán-Infante, L. Nics, T. Traub-Weidinger, M. Mitterhauser, W. Wadsak, M. Hacker, S. Kasper, R. Lanzenberger,
    NeuroImage, 2017,
  18. New avenues for targeted therapies and biomarkers in anaplastic large cell lymphoma
    Gerda Egger & Suzanne D Turner
    Epigenomics, 2017,
  19. Methoxinine - an alternative stable amino acid substitute for oxidation-sensitive methionine in radiolabelled peptide conjugates
    Nathalie M Grob, Martin Behe, Elisabeth Von Guggenberg, Thomas Mindt
    Journal of Peptide Science, 2017,
  20. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
    Danielle J. Vugts, Chris Klaver, Claudia Sewing, Alex J. Poot, Kevin Adamzek, Seraina Huegli, Cristina Mari, Gerard W. M. Visser, Ibai E. Valverde, Gilles Gasser, Thomas L. Mindt, and Guus A. M. S. van Dongen
    Eur J Nucl Med Mol Imaging, 2017,
  21. A solid phase-assisted approach for the facile synthesis of a highly water-soluble zirconium-89 chelator for radiopharmaceutical development
    Manon Briand, Margaret L. Aulsebrook, Thomas L. Mindt and Gilles Gasser
    Dalton Transactions, 2017,
  22. Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer
    Jens Cardinale, René Martin, Yvonne Remde, Martin Schäfer, Antje Hienzsch, Sandra Hübner, Anna-Maria Zerges, Heike Marx, Ronny Hesse, Klaus Weber, Rene Smits, Alexander Hoepping, Marco Müller, Oliver C. Neels and Klaus Kopka
    Pharmaceuticals 2017,
  23. Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight
    Heinz H. Coenen, Antony D. Gee, Michael Adam, Gunnar Antoni, Cathy S. Cutler, Yasuhisa Fujibayashi, Jae Min Jeong, Robert H. Mach, Thomas L. Mindt, Victor W. Pike, Albert D. Windhorst,
    Nuclear Medicine and Biology, 2017,
  24. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors
    Theodosia Maina, Aikaterini Kaloudi, Ibai E. Valverde, Thomas L. Mindt, Berthold A. Nock
    Nuclear Medicine and Biology, 2017,
  25. Guidance on validation and qualification of processes and operations involving radiopharmaceuticals
    S. Todde, Kolenc Peitl, P. Elsinga, J. Koziorowski, V. Ferrari, E. M. Ocak, O. Hjelstuen, M. Patt, T. L. Mindt, M. Behe
    EJNMMI Radiopharmacy and Chemistry, 2017,
  26. Costing evidence for health care decision-making in Austria: A systematic review
    Susanne Mayer, Noemi Kiss, Agata Łaszewska, Judit Simon
    PLOS, 2017,
  27. State estimation for a penicillin fed-batch process combining particle filtering methods with online and time delayed offline measurements
    Julian Kager, Christoph Herwig, Ines Viktoria Stelzer,
    Chemical Engineering Science, 2017,
  28. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria
    Chiara Feig, Kei Long Cheung , Mickaël Hiligsmann, Silvia M. A. A. Evers, Judit Simon & Susanne Mayer
    Expert Review of Pharmacoeconomics & Outcomes Research, 2017,
  1. [18F]FE@SNAP—a specific PET tracer for melanin-concentrating hormone receptor 1 imaging?

    Cécile Philippe, Daniela Haeusler, Thomas Scherer, Clemens Fürnsinn, Markus Zeilinger, Wolfgang Wadsak, Karem Shanab, Helmut Spreitzer, Marcus Hacker, and Markus Mitterhauser

    EJNMMI Res., 2016,

  2. Glycated 99mTc-Tricarbonyl-Labeled Peptide Conjugates for Tumor Targeting by “Click-to-Chelate”

    Karolin Rçmhild, ChristianeA.Fischer, and Thomas L. Mindt

    ChemMedChem, 2016,

  3. Toward the Optimization of Bombesin-Based Radiotracers for Tumor Targeting

    Ibai E. Valverde, Sandra Vomstein, and Thomas L. Mindt

    J. Med. Chem., 2016,

Share This: